Private Advisor Group LLC Has $173,000 Holdings in Tilray Inc (NASDAQ:TLRY)

Private Advisor Group LLC decreased its position in Tilray Inc (NASDAQ:TLRY) by 26.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 130,046 shares of the company’s stock after selling 47,247 shares during the period. Private Advisor Group LLC’s holdings in Tilray were worth $173,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of TLRY. Wealth Enhancement Advisory Services LLC raised its holdings in shares of Tilray by 22.6% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 39,819 shares of the company’s stock valued at $70,000 after purchasing an additional 7,339 shares during the period. Bank of Montreal Can raised its holdings in shares of Tilray by 0.3% during the third quarter. Bank of Montreal Can now owns 2,176,506 shares of the company’s stock valued at $3,787,000 after purchasing an additional 7,406 shares during the period. Newman Dignan & Sheerar Inc. raised its holdings in shares of Tilray by 61.9% during the fourth quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company’s stock valued at $35,000 after purchasing an additional 10,000 shares during the period. Ferguson Wellman Capital Management Inc. acquired a new position in shares of Tilray during the third quarter valued at about $26,000. Finally, KBC Group NV raised its holdings in shares of Tilray by 75.9% during the fourth quarter. KBC Group NV now owns 38,332 shares of the company’s stock valued at $51,000 after purchasing an additional 16,539 shares during the period. Institutional investors and hedge funds own 9.35% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group boosted their target price on shares of Tilray from $2.00 to $3.00 and gave the stock a “buy” rating in a research report on Monday, January 13th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $2.70.

Tilray Trading Down 5.9 %

Shares of TLRY stock opened at $0.68 on Friday. The company has a 50 day moving average of $1.07 and a 200-day moving average of $1.39. The company has a quick ratio of 1.58, a current ratio of 2.54 and a debt-to-equity ratio of 0.10. Tilray Inc has a 12-month low of $0.64 and a 12-month high of $2.97. The firm has a market cap of $633.67 million, a P/E ratio of -2.25 and a beta of 2.13.

Tilray (NASDAQ:TLRY) last issued its quarterly earnings results on Friday, January 10th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.07). The company had revenue of $210.90 million for the quarter, compared to analysts’ expectations of $216.34 million. Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. The business’s quarterly revenue was up 8.7% on a year-over-year basis. Sell-side analysts anticipate that Tilray Inc will post -0.2 earnings per share for the current year.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.